1. Introduction {#s0005}
===============

Many neuroimaging studies to date have investigated brain abnormalities associated with the diagnosis of Alzheimer\'s disease (AD), most often using magnetic resonance imaging (MRI), ^18^F-fluorodeoxyglucose-positron emission tomography (^18^F-FDG-PET) to measure regional brain metabolism, and single photon emission computed tomography (SPECT) to measure regional cerebral blood flow (rCBF SPECT) ([@bb0130], [@bb0175], [@bb0245], [@bb0365]). These studies have typically carried out comparisons of mean imaging indices between samples of AD patients and healthy elderly controls across separate brain regions using either regions of interest (ROIs) ([@bb0140], [@bb0155], [@bb0240], [@bb0255]) or voxel-based techniques, applying mass univariate approaches for statistical inference ([@bb0140], [@bb0155], [@bb0180]). These imaging studies have identified abnormalities in several brain regions in association with the diagnosis of AD from early stages of the disease onwards ([@bb0225], [@bb0310], [@bb0350]). When such traditional mass-univariate approach is used, the detection of the relevance of different brain regions to characterize AD is straightforward; since each ROI or voxel is treated independently, thresholds based on statistical significance and spatial extent can be applied to the statistical parametric results in order to select clusters of voxels with greatest relevance to distinguish AD patients from controls ([@bb0015], [@bb0050], [@bb0110], [@bb0120], [@bb0135]).

More recently, a number of neuroimaging investigations of AD have applied machine learning (ML) techniques that allow detection of spatially complex and often subtle neuroimaging patterns of brain abnormalities in individual subjects, building high-dimensional classifiers based on multivariate methods that simultaneously assess multiple voxels within the brain space ([@bb0070], [@bb0085], [@bb0145], [@bb0295], [@bb0380]). Rather than determining statistical group differences, this approach allows classification of images of each subject, providing individual predictions which might ultimately be used in the clinical context ([@bb0095], [@bb0185], [@bb0280], [@bb0310], [@bb0380]). In contrast with the above mass-univariate strategies, the determination of the most relevant voxels that characterize the difference between groups is not as easily achieved in ML-based approaches, as the weight of each voxel to classify groups depends on all the other voxels, in a multivariate model. In order to address this problem, strategies aiming to select the most relevant voxels to be used as input to the models may be sought to facilitate the interpretation of the weight maps.

In recent years, Multiple Kernel Learning (MKL) approaches have been proposed to combine multiple sources of data in ML algorithms. Up to the present date, the MKL approach has been applied to neuroimaging data predominantly to combine different representations (usually two or more imaging modalities) ([@bb0115], [@bb0160]). However, some recent pilot investigations have proposed models in which subsets of features are used as sources of data ([@bb0055], [@bb0370]). If these subsets of features are extracted according to some neuroanatomical criterion, it is possible to obtain predictions based on anatomical localization ([@bb0235]) and to help to determine which are the most relevant brain regions that contribute to group classification.

In the present study, we aimed to investigate the predictive power of MKL models using ROIs (MKL-ROI) to classify patients with mild AD versus age- and gender-matched healthy controls, using a multimodal neuroimaging approach comprising morphological MRI, ^18^F-FDG-PET and rCBF-SPECT data. In contrast with the vast majority of ML-based studies of AD using multimodal imaging designs, we examined exactly the same subjects using the three neuroimaging modalities, with short time intervals between the scanning sessions. We aimed to rank the brain regions affording the greatest degree of discrimination between AD patients and controls according to their contributing weights in each imaging modality, and to establish whether the contribution of each brain region was due to predominantly increased or decreased voxel values in AD patients compared to controls. In addition, diagnostic accuracy indices obtained with the MKL-ROI approach were compared to the indices obtained with Support Vector Machine (SVM) based on the whole-brain. Finally, since recent investigations have suggested that the choice of brain atlas for feature extraction may exert a significant influence on the accuracy of MRI or PET-FDG data in SVM studies of elderly populations ([@bb0260]), we compared MKL-ROI results obtained with two different atlases to delineate ROIs, in order to verify the robustness of the accuracies and ranking of weights for each selected brain region.

2. Material and Methods {#s0010}
=======================

2.1. Subjects {#s0015}
-------------

Thirty-eight individuals were enrolled in this study (20 patients with mild AD and 18 healthy elderly volunteers). The investigation was approved by the ethical committee of the involved institutions and all participants provided informed consent. For both groups, the exclusion criteria were as follows: less than four years of education, age below 60 or above 90 years, use of psychotropic drugs, diabetes mellitus, presence of systemic disorders associated with cognitive decline, contra-indications for MRI and brain lesions incidentally detected on MRI.

All patients fulfilled the DSM-III-R ([@bb0005]) and NINCDS/ADRDA ([@bb0190]) criteria for mild dementia and probable AD. Their Clinical Dementia Rating (CDR) scale was lower or equal to 1 ([@bb0215]). As the data were collected before the publication of the new 2011 NINCDS/ADRDA criteria for Alzheimer\'s disease ([@bb0195]), the criteria for probable Alzheimer\'s disease from 1984 were used ([@bb0190]).

Healthy controls did not present memory deficits or cognitive impairments (CDR = 0). [Table 1](#t0005){ref-type="table"} presents age, gender, education and results from Mini Mental State Examination (MMSE) of AD patients and healthy volunteers. Further details regarding the demographic and clinical characteristics of AD subjects and controls can be found in ([@bb0040]).Table 1Demographic characteristics of the participants.Table 1Healthy participantsPatients with AD*p*-valueAge: mean (SD)72.7 (4.2)75.5 (4.0)0.06Sex: male (female)7 (11)9 (11)0.70Education in years: mean (SD)10.4 (4.8)7.3 (3.9)0.05MMSE: mean (SD)28.1 (1.3)21.3 (2.8)\< 0.01[^1]

2.2. Image acquisition and pre-processing {#s0020}
-----------------------------------------

### 2.2.1. T1 Magnetic Resonance Imaging (T1-MRI) {#s0025}

Spin echo T1-weighted images were obtained on the sagittal plane with the following parameters: TR 12.1, TE 4.1999, flip angle 15^o^, pixel bandwidth 88.75, matrix 256 × 256, voxel size 0.86 × 0.86 × 1.6 mm, 204 slices, slice thickness 1.6. These images were acquired using a General Electric-Horizon LX 8.3 1.5 Tesla scanner (Milwaukee, WI, USA).

Non-brain tissues were removed from the T1-MRI anatomical images applying the Hybrid Watershed algorithm ([@bb0320]), implemented in Freesurfer v.3.04 (Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts, USA; <http://surfer.nmr.mgh.harvard.edu>). The N3 algorithm, ([@bb0335]) also implemented in Freesurfer, was used to perform intensity normalization. The Brain Extraction Tool ([@bb0340]) implemented in FSL (Oxford\'s Functional MRI Software of the Brain Library, UK; [www.fmrib.ox.ac.uk/fsl](http://www.fmrib.ox.ac.uk/fsl){#ir0010}) was used to perform a final non-brain tissue removal ([@bb0275]).

Images were then segmented into gray matter (GM) and white matter partitions using the unified segmentation procedure ([@bb0020]) as implemented in SPM8 (Statistical Parametric Mapping software, version 8; <http://www.fil.ion.ucl.ac.uk/spm>; Wellcome Department of Imaging Neuroscience, London). The segmented images were spatially normalized to the standard MNI space using the Diffeomorphic Anatomical Registration Through Exponentiated Lie Algebra (DARTEL) algorithm ([@bb0010]). This procedure maximizes the sensitivity and accuracy of localization by registering individual structural images to an asymmetric custom T1-weighted template derived from the participants\' structural images rather than to a standard T1-weighted template based on a different sample ([@bb0065]). The normalized GM images were resliced with trilinear interpolation to a final voxel size of 2 × 2 × 2 mm^3^. An additional procedure was performed to modulate the images, consisting of multiplying each spatially normalized GM image by its relative volume before and after normalization; this ensured that the total amount of GM in each voxel was preserved. Finally, the resulting GM images were smoothed using an 8 mm isotropic kernel at full width half maximum (FWHM).

### 2.2.2. Positron Emission Tomography (PET) {#s0030}

All subjects had blood glucose levels determined in the beginning of the PET scanning session. After a period of at least 6 h of fasting, they received 370 MBq of \[18F\] fluoro-2-D-deoxyglucose (FDG). Imaging started 60 min after FDG administration, using a 3-D protocol with acquisition time of 15 min. The acquisition was performed using a dedicated LSO-PET 16-slice CT scanner (Biograph-16, Siemens, Illinois-USA). The matrix size was 256 × 256 with a smoothing factor of 5. Iterative reconstruction (OSEM) was applied according to a standardized protocol in our institution. Attenuation was corrected using the CT-algorithm.

^18^F-FDG-PET images were coregistered to the skull striped T1-MRI in its native space using SPM8. Partial volume effects (PVE) correction was applied to the coregistered images to avoid confounding effects related to regional brain atrophy ([@bb0065]). The Meltzer method ([@bb0200]), a voxel-based PVE correction algorithm implemented in the PVElab software (<http://nru.dk/downloads/software>) ([@bb0285]) was applied.

The spatial transformation parameters resulting from the T1-MRI normalization steps (described above) were applied to ^18^F-FDG-PET images in order to achieve spatial normalization to the standard MNI space. The normalized images were smoothed with a Gaussian filter of 8 mm at FWHM. Normalization of images to the global tracer uptake was performed by dividing the value of each voxel by the average of all voxels belonging to a whole-brain mask.

### 2.2.3. Single Photon Emission Computed Tomography (SPECT) {#s0035}

The subjects received IV injection of 20 mCi (740 MBq) of ^99m^Tc-ECD 30 min before the images acquisition. A dual-detector SPECT camera equipped with a fan beam collimator (ECAM, Siemens, Hoffmann Estates, Illinois) was used. SPECT images were processed according to a standard protocol, with no attenuation correction and a Butterworth post filtering. The reconstruction yielded 4.8 mm voxels with a 128 × 128 matrix and 128 slices. In-plane spatial resolution was 10.6/6.7 mm full width at a half maximum (FWHM) in the center of view. Images were reconstructed with scatter correction. The rCBF-SPECT images were also coregistered to the skull striped T1-MRI in its native space using SPM8 and corrected for PVE using the Meltzer as described for the ^18^F-FDG-PET data ([@bb0200]).

Spatial normalization using transformation parameters resulting from the T1-MRI data, Gaussian smoothing (8 mm at FWHM) and normalization to global tracer uptake were conducted using the same methods described above for the ^18^F-FDG-PET data.

2.3. Classification techniques {#s0040}
------------------------------

In supervised learning, classification corresponds to the task of identifying to which of a set of categories a new example belongs, based on a training set of data containing examples whose membership is previously known.

### 2.3.1. Learning from a single source {#s0045}

Individual examples are often represented by a set of quantifiable properties, known as explanatory variables or features. These properties may be categorical, ordinal, integer-valued or real-valued (e.g. a measurement of intensity of voxels in brain images). Thus, a source of information can be represented by a data matrix *X* composed by *n* examples and *p* features. In neuroimaging-based classification, each feature may correspond to a single voxel and each example may correspond to an anatomical scan from a single subject, for example. Many classifiers work by comparing examples by means of a similarity or distance function (*kernels*). A function is used to build kernel matrices, whose dimensions correspond to the number of examples. In our analyses, we applied a linear kernel given by the scalar product of the data matrix:$$K = X \bullet X^{T}$$

In a binary classification (2 classes), the examples (e.g. images from each subject *x*~*i*~ *ϵ R*^*n*^) are associated to labels *y*~*i*~, which can assume one of two possible values (− 1 or 1).

In this study, we used SVM ([@bb0025], [@bb0360]) to classify AD patients and healthy controls. The linear SVM is defined as an optimization problem that can be represented through a dual formulation, where *n* is the number of training examples, *α*~*i*~ is the contribution of the *i-th* training example to the final solution, *y*~*i*~ is the label of the *i-th* training example and *C* is a regularization parameter that controls the distance between the hyperplane and the support vectors.$$\binom{\max}{\mathsf{\alpha}_{\mathsf{i}}} - \frac{1}{2}\sum\limits_{\mathsf{i},\mathsf{j}}^{\mathsf{n}}\mathsf{y}_{\mathsf{i}}\mathsf{y}_{\mathsf{j}}{\overset{\rightarrow}{\mathsf{x}}}_{\mathsf{i}\mspace{9mu}}.{\overset{\rightarrow}{\mathsf{x}}}_{\mathsf{j}}\mathsf{\alpha}_{\mathsf{i}}\mathsf{\alpha}_{\mathsf{j}} + \sum\limits_{\mathsf{i} = 1}^{\mathsf{n}}\mathsf{\alpha}_{\mathsf{i}}$$$$\mathsf{such\ that}\ \sum\limits_{\mathsf{i} = 1}^{\mathsf{n}}\mathsf{\alpha}_{\mathsf{i}}\mathsf{y}_{\mathsf{i}} = 0\ \mathsf{and}\ 0 \leq \mathsf{\alpha}_{\mathsf{i}} \leq \mathsf{C}$$

Once this equation is solved, *α*~*i*~ and *b* are determined and can be used to classify a test example $\overset{\rightarrow}{x}$ based on the following equation, which classifies $\overset{\rightarrow}{x}$ as either 1 or − 1.$$\mathsf{f}\left( \overset{\rightarrow}{\mathsf{x}} \right) = \operatorname{sign}\ \left\lbrack {\sum\limits_{\mathsf{i} = 1}^{\mathsf{n}}\mathsf{\alpha}_{\mathsf{i}}\mathsf{y}_{\mathsf{i}}\ \mathsf{K}\ \left( {{\overset{\rightarrow}{\mathsf{x}}}_{\mathsf{i}\mspace{9mu}},\overset{\rightarrow}{\mathsf{x}}} \right) - \mathsf{b}} \right\rbrack$$

We fixed the regularization parameter C at the value 1 in all analyses, as our aim was not to maximize the accuracy, but instead to provide a comparison across modalities and atlases using ROI-based MKL.

### 2.3.2. Learning from multiple sources {#s0050}

With the growing application of ML models based on neuroimaging in neuroscience and clinical investigations, a topic that becomes increasingly relevant is interpretability (i.e. which areas of the brain mostly contribute to the predictions provided by the models). In a clinical application, this information can provide insights about how a psychiatric or neurologic disorder affects the brain ([@bb0235]). However, since the prediction is based on a multivariate pattern, all features given as input to the model contribute to generate a predictive function. The issue of model interpretability is particularly relevant when using algorithms that have non-sparse weights associated to the features, as in the case of SVM ([@bb0300]).

In neuroimaging, different data sources may comprise different imaging modalities (e.g., T1-MRI or FDG-PET), different ways of extracting data from a same modality (e.g., volumetric or cortical thickness in structural MRI), or different feature subsets. In the present study, we are interested in the latter approach (i.e., using feature subsets as kernels and combining them). We are particularly interested in investigating models based on subsets of features extracted according to anatomical criteria, in order to obtain predictions that are meaningful in regard to anatomical localization. We use the acronym MKL-ROI throughout the text to represent this approach (distinguishing it from other potential uses of MKL methods to combine other kinds of sources of data).

#### 2.3.2.1. Multi-Kernel Learning (MKL) {#s0055}

Kernel methods can operate on very general types of data and can detect different types of relations. Thus, they provide a natural way to merge and integrate different sources of information. Recent applications have shown that using multiple kernels instead of a single one can enhance the interpretability of the decision function, and in some cases improve the final performance. A convenient approach is to consider that the kernel *K*(*x*, *x*′) is actually a convex combination of *basis* kernels ([@bb0150]):$$\mathsf{K}\left( {\mathsf{x},\mathsf{x}^{\prime}} \right) = \sum\limits_{\mathsf{m} = 1}^{\mathsf{M}}\mathsf{d}_{\mathsf{m}}\mathsf{K}_{\mathsf{m}}\left( {\mathsf{x},\mathsf{x}^{\prime}} \right),\mathsf{with}\ \mathsf{d}_{\mathsf{m}} \geq 0,\sum\limits_{\mathsf{m} = 1}^{\mathsf{M}}\mathsf{d}_{\mathsf{m}} = 1$$

In Eq. [(5)](#fo0025){ref-type="disp-formula"} *M* is the total number of kernels. Within this framework, the problem of data representation through the kernel is transferred to the choice of weights *d*~*m*~. Learning both the coefficients *i* and the weights *d*~*m*~ in a single optimization problem is known as the MKL problem. In the current investigation, we applied the algorithm SimpleMKL ([@bb0290]) available in the toolbox PRoNTo ([@bb0315]).

SimpleMKL consists in optimizing problems addressed by SVM by computing an optimal weighting. The minimization problem includes a constraint on the *L1* norm of the vector *d*, which induces sparsity in the solution. This property allows the model to keep only the most relevant patterns in the kernel computation. The SimpleMKL problem is solved by alternating a classical SVM together with a projected gradient descendent according to vector *d*, allowing to minimize the objective function while ensuring that constraints on vector *d* are fulfilled. The *L-norm* constraint on the vector *d* is a sparsity parameter that forces some kernels to have zero weight, thus encouraging sparse basis kernel expansions. The mixed-norm (L1 and L2) penalization of *d*~*m*~*K*~*m*~(*x*, *x*^′^) is a soft-thresholding penalizer that leads to a sparse solution, for which the algorithm performs kernel selection. Thus, the procedure to find the number of selected kernels (ROIs) is based on Gradient descent ([@bb0170]), that minimizes a cost function aiming the minimum error in fitting parameters to the training data.

#### 2.3.2.2. ROI-based MKL {#s0060}

In this study, we are interested in investigating the anatomical localization of the features that contribute the most to classify AD patients and healthy controls. Thus, we applied an MKL approach in which each data source corresponds to subsets of the features in the brain. To obtain subsets of voxels with anatomical meaning we used parcellation templates (brain atlases) to provide ROIs.

In order to investigate to what extent different criteria of anatomical segmentation affect the MKL-ROI performance, we carried out separate analyses using two atlases: Automated Anatomical Labeling (AAL) atlas ([@bb0355]) and Brodmann\'s Areas (BA) atlas ([@bb0035]) furnished by the software MRICRO ([@bb0305]). Regions belonging to the cerebellum were not included, as the effect of AD neuropathology on this area is thought to be minimal, at least in the early stages of the disease ([@bb0100], [@bb0210]). Each structure in the AAL atlas is associated to two ROIs (in the left and right hemispheres); on the other hand, the BA atlas encompasses bilateral regions. Therefore, in order to make the two atlases more comparable with each other, we merged the left and right regions for each structure in the AAL atlas into a single ROI. Thus, we worked with 45 regions from the AAL atlas and 48 regions from the BA atlas. However, the number of selected regions varies across the analyses reported, due to the fact that the SimpleMKL is a sparse method (i.e., null weight is assigned to several kernels during the learning process).

[Fig. 1](#f0005){ref-type="fig"} illustrates the framework of the MKL-ROI approach. The atlas provides anatomical ROIs, represented in colours in the figure. Each ROI is defined by a disjoint set of voxels with unique indices in a standard three-dimensional space. As the features correspond to individual voxels, each ROI is considered a features set (represented by F~1~ to F~M~ in the figure). Voxels in the training images from both groups (patients and healthy controls) corresponding to the indices of each ROI compose the kernel matrices (K~1~ to K~M~). They encode similarity measures of each pair of examples (images from each training subject limited by a mask defined by the particular ROI). The SimpleMKL algorithm optimizes the weights of each kernel in a sparse way, so that only a subset of kernels have non-zero weight in the learned classification function (ƒ~MKL~ in the figure)~.~ The complete process is performed inside a cross-validation loop. Thus, after all iterations, a set of selected ROIs and their respective weights is obtained. Additionally, as each voxel correspond to a particular feature, the voxels belonging to the selected ROIs are also associated to individual weights. This concept is more formally detailed in [Section 2.5](#s0070){ref-type="sec"}, where we define the terms 'ROI-weight' and 'voxel-weight', which will be important to evaluate the predominance of hypometabolism/atrophy or hypermetabolism/hypertrophy for each region in a subsequent analysis.Fig. 1MKL-ROI framework. The atlas consists of anatomical ROIs represented in different colours. Each ROI is defined by a disjoint set of voxels with unique indices in a standard three-dimensional space. These are subsets of voxels (features) represented by F~1~ to F~M~. The training images from both groups (patients and healthy controls) limited by the indices of each ROI compose each kernel matrix (K~1~ to K~M~). The SimpleMKL algorithm optimizes the weights of each kernel in a sparse way, so that only a subset of kernels have non-zero weight in the classification function (ƒ~MKL~)~.~ The complete process is performed inside a cross-validation loop, resulting in a list of selected (non-zero) ROIs, from which the final accuracy is obtained.Fig. 1

2.4. Validation {#s0065}
---------------

The predictive performance for each method is given by the balanced average (BA) between the proportions of true positive (TP) and true negative (TN) (i.e. patients and controls correctly classified, respectively).

We used cross-validation to assess how the results of the classification analyses could generalize to an independent data set. One round of cross-validation involves partitioning the data sample into disjoint subsets of examples, performing the analysis on one subset (the training set), and validating the analysis on the other subset (the validation or testing set). To reduce variability, multiple rounds of cross-validation are performed using different partitions, and the validation results are averaged over the rounds. In the present study, we used a leave-one-subject-out cross-validation (LOO-CV), which involves separating a single example (either patient or control) from the complete sample for test while the remaining examples are used for training. This splitting is repeated so that each example in the whole sample is used once for validation. After all iterations, the final accuracy is quantified as the average of accuracies obtained across all folds. The balanced accuracy is computed from a set of class-specific accuracies, taking the number of samples in each class into account.

To evaluate whether the resulting classification accuracy is statistically significant, we used a permutation test with 10,000 repetitions. In this non-parametrical test, the labels are randomly permuted across examples and the classification procedure is repeated a high number of times. The probability of having obtained the result by chance is given by the count of the number of instances when the classification with permuted labels outperforms the original classification (with the correct labels). This count is divided by the number of repetitions to obtain a percentage value *p.*

2.5. Weights in selected brain regions {#s0070}
--------------------------------------

As both coefficients α~i~ and *d*~m~ are learnt in a single optimization problem (linear eqs. [(4)](#fo0020){ref-type="disp-formula"}, [(5)](#fo0025){ref-type="disp-formula"}), besides the weight associated to each kernel, the weight of each feature in the selected regions can also be recovered. For clarity of presentation, from now on we will refer to the weight assigned to each kernel as 'ROI-weight' and to the weight assigned to each feature as 'voxel-weight'. In the training of the classifier, the label + 1 was assigned to the class corresponding to the AD group and the label − 1 was assigned to the healthy control group. Thus, a positive voxel-weight indicates relatively higher radiotracer uptake (PET and SPECT data) or increased GM volume (T1-MRI) in the AD group when compared to the healthy control group whereas a negative voxel-weight indicates higher radiotracer uptake or increased GM volume in the healthy control group for the particular location.

For each ROI we wanted to characterize if the predominant type of changes were related to either hypometabolism/atrophy or hypermetabolism/structural preservation. Thus we calculated the ratio between positive and negative voxel-weights within each selected ROI, performing the following steps:1.Obtained the probability density function of the voxel-weight vector;2.Calculated the area under curve separately for negative and positive voxel-weights (*AUC***-** and *AUC* +*,* respectively);3.Obtained the ratio *rAUC = AUC* −/*AUC +*.

Using *rAUC* we characterized the selected ROIs according to the predominance of signal: regions for which *rAUC* was close to 1 were considered to be mixed (i.e. balanced positive and negative voxel-weights). Values close to zero suggest regions that have predominantly positive voxel-weights and values higher than one suggest regions that have predominantly negative voxel-weights.

3. Results {#s0075}
==========

3.1. Classification performance across modalities and atlases {#s0080}
-------------------------------------------------------------

In this section we present the performance of the classification of AD patients and healthy controls for all modalities using whole-brain SVM ([Table 2](#t0010){ref-type="table"}a) and using MKL-ROI with both atlases considered: AAL ([Table 2](#t0010){ref-type="table"}b) and BA ([Table 2](#t0010){ref-type="table"}c). For each analysis we present the balanced accuracy, the sensitivity (described as true positive - the proportion of patients correctly classified) and the specificity (described as true negative -- the proportion of healthy controls correctly classified).Table 2Classification results.Table 2ModalityNSRNFTPTNBA*p*T1-MRI--219,72770.00%77.78%73.89%0.013^18^F-FDG-PET--219,72785.00%83.33%84.17%\< 0.001rCBF-SPECT--219,72775.00%88.89%81.94%\< 0.001(a)SVM (Whole-brain)  T1-MRI2064,60580.00%72.22%76.11%0.016^18^F--FDG-PET2371,67385.00%100.00%92.50%\< 0.001rCBF-SPECT1859,28685.00%83.33%84.17%\< 0.001(b)MKL-ROI (AAL atlas)  T1-MRI1966,11170.00%66.67%68.33%0.080^18^F--FDG-PET2164,19785.00%100.00%92.50%\< 0.001rCBF-SPECT1758,97570.00%77.78%73.89%0.018(c)MKL-ROI (BA atlas)[^2]

For the whole-brain SVM analyses, similar accuracies were obtained using ^18^F-FDG-PET (84.17%) and rCBF-SPECT (81.94%). Using T1-MRI, the accuracy was lower (73.89%) in comparison with both functional modalities.

For MKL-ROI analyses, the best accuracy was obtained with ^18^F-FDG-PET, followed by rCBF-SPECT and T1-MRI for both atlases. For ^18^F-FDG-PET, the accuracy obtained with the BA atlas was the same as the accuracy obtained with AAL atlas (92.50%). Conversely, for both T1-MRI and rCBF-SPECT, the accuracy obtained with AAL atlas was higher than the accuracy obtained with the BA atlas (respectively 76.11% versus 68.33% for T1-MRI, and 84.17% versus 73.89% for rCBF-SPECT) ([Tables 2](#t0010){ref-type="table"}b and [2](#t0010){ref-type="table"}c).

The number of selected ROIs (NSR) was slightly higher for the AAL atlas than for the BA atlas in the three modalities, although the actual number of features used as input for the MKL-ROI models (NF) varies across them. It is interesting to notice that even though the accuracies resulting from MKL-ROI analyses with AAL atlas was higher than the accuracies obtained using whole-brain SVM for all modalities, the number of selected ROIs was considerably low. Out of 45 ROIs, 20 were selected in T1-MRI, 23 in ^18^F-FDG-PET and 18 in rCBF-SPECT, corresponding to respectively 29%, 33% and 27% of the total number of voxels. For the BA atlas, out of 48 ROIs, 19 were selected on T1-MRI, 21 on ^18^F-FDG-PET and 17 on rCBF-SPECT, corresponding to respectively 30%, 29% and 27% of the total number of voxels. These results show that the models are substantially sparse, providing good accuracy indices using only the most relevant features.

In [Fig. 2](#f0010){ref-type="fig"} we show the Receiver Operating Characteristic (ROC) curves (plots of the true positive rate against the false positive rate for the different possible cut points) for each analysis presented in [Table 2](#t0010){ref-type="table"}. Plots (a)--(c) were derived from SVM using the whole-brain for T1-MRI, FDG-PET and rCBF-SPECT, respectively. Plots (d)--(f) were derived from MKL-ROI using the Brodmann atlas and plots (g)--(i) were derived from MKL-ROI using the Brodmann atlas. The area under curve (AUC) is presented in each plot.Fig. 2ROC curves. (a) Whole-brain-based SVM using T1-MRI; (b) Whole-brain-based SVM using FDG-PET; (c) Whole-brain-based SVM using rCBF-SPECT; (d) AAL-based MKL-ROI using T1-MRI; (e) AAL-based MKL-ROI using FDG-PET; (f) AAL-based MKL-ROI using rCBF-SPECT; (g) Brodmann-based MKL-ROI using T1-MRI; (h) Brodmann-based MKL-ROI using FDG-PET; (i) Brodmann-based MKL-ROI using rCBF-SPECT.Fig. 2

3.2. Selected brain regions and relevance {#s0085}
-----------------------------------------

In [Table 3](#t0015){ref-type="table"}, [Table 4](#t0020){ref-type="table"}, we present the brain regions which were selected by MKL-ROI to classify AD patients and healthy controls using the AAL and BA atlases, respectively. For each modality (T1-MRI, ^18^F-FDG-PET and CBF-SPECT), the selected ROIs were sorted in descending order of ROI-weight.Table 3Regions from AAL atlas selected by MKL-ROI to classify AD patients and healthy controls.Table 3[^3]Table 4Regions from BA atlas selected by MKL-ROI to classify AD patients and healthy controls.Table 4[^4]

In the analyses using the AAL atlas ([Table 3](#t0015){ref-type="table"}), although several cortical and subcortical regions contributed to the discrimination between AD patients and controls, highly prominent ROI-weights were detected in: the posterior cingulate gyrus (around 30% of the total ROI-weight), fusiform gyrus and cuneus (around 15% each) for PET; the posterior cingulate gyrus (around 25%), fusiform gyrus and angular gyrus (around 20% each) for SPECT; and the inferior temporal gyrus and caudate nucleus (both around 20%) for T1-MRI ([Table 3](#t0015){ref-type="table"}). In the analyses using the BA atlas, a similar pattern involving several brain foci but with greater emphasis on a few selected regions emerged ([Table 4](#t0020){ref-type="table"}). However, there were differences in regard to brain location and attributed ROI-weights relative to the analyses using the AAL atlas, with greatest ROI-weights detected in: the medial parietal cortex (around 35%) and parahippocampal gyrus (around 15%) for PET; the medial parietal cortex (around 25%), secondary visual cortex (around 20%) and posterior cingulate gyrus (around 15%) for SPECT; and entorhinal cortex, posterior cingulate gyrus, inferior and auditory temporal gyri (each around 15% of the total ROI-weight) for T1-MRI ([Table 4](#t0020){ref-type="table"}).

The data presented in [Table 3](#t0015){ref-type="table"}, [Table 4](#t0020){ref-type="table"} also provide the description of brain regions in which voxels with lower or higher values predominated in AD patients relative to controls (as ascertained by the ratio between positive and negative voxel-weights within each ROI - rAUC). These analyses demonstrated that for the three imaging modalities, most regions presented rAUC above 1, indicating a predominant pattern of hypometabolism/atrophy. A number of brain regions presented rAUC values below 1; thus the ROI-weight of discrimination in these regions was mostly due to a pattern of increased (rather than decreased) voxel-weight values in AD individuals, indicating relative hypermetabolism/structural preservation in AD patients relative to controls. Most of the ROIs that presented such pattern encompass brain regions typically spared in mild stages of AD, including: the visual cortex, primary motor and somatosensory cortices, subcortical nuclei (caudate, putamen, pallidum and thalamus) and orbitofrontal cortex ([Table 3](#t0015){ref-type="table"}, [Table 4](#t0020){ref-type="table"}).

[Fig. 3](#f0015){ref-type="fig"} and [Fig. 4](#f0020){ref-type="fig"} illustrate the selected brain regions in colours according to the ROI-weight assigned to them by the MKL-ROI classification using the AAL and BA atlases respectively. Each modality is shown in a separate panel: T1-MRI ([Fig. 3](#f0015){ref-type="fig"}a and [Fig. 4](#f0020){ref-type="fig"}a); ^18^F--FDG-PET ([Fig. 3](#f0015){ref-type="fig"}b and [Fig. 4](#f0020){ref-type="fig"}b) and rCBF-SPECT ([Fig. 3](#f0015){ref-type="fig"}c and [Fig. 4](#f0020){ref-type="fig"}c).Fig. 3ROIs from AAL atlas selected by MKL-ROI to classify AD patients and healthy controls. The regions were overlapped on a structural template and their colour varies from light yellow (minimum ROI-weight) to red (maximum ROI-weight).Fig. 3Fig. 4ROIs from BA atlas selected by MKL-ROI to classify AD patients and healthy controls. The regions were overlapped on a structural template and their colour varies from light yellow (minimum ROI-weight) to red (maximum ROI-weight).Fig. 4

[Fig. 5](#f0025){ref-type="fig"} presents examples of voxel-weights within ROIs BA7 and BA37 to illustrate the heterogeneity of the regions regarding the signal of weights assigned to each feature as well as the presence of spatial clusters of similar weights.Fig. 5Voxel-weight in BA areas 37 and 7: (a) 18F--FDG-PET; (b) rCBF-SPECT.Fig. 5

[Fig. 6](#f0030){ref-type="fig"} and [Fig. 7](#f0035){ref-type="fig"} present the predominance of positive and negative signal in the voxel-weights of each ROI selected using the AAL and BA atlases, respectively. The colour in each region represents the *rAUC.* Cool colours represent predominance of hypometabolism/atrophy in AD patients while warm colours indicate relative hypermetabolism/structural preservation.Fig. 6Predominance of signal in voxel-weights. The colours represent the rAUC (ratio between AUC- and AUC +) for each selected ROI in the AAL atlas. For clarity, rAUC was normalized independently for each modality so that cool colours (from purple to light blue) always represent rAUC \< 1 (i.e., regions with predominantly positive voxel-weights). In the same way, warm colours (from yellow to red) represent rAUC \> 1 (regions with predominantly negative voxel-weights) and greenish colours represent regions with rAUC close to 1 (no clear predominance of signal).Fig. 6Fig. 7Predominance of signal in voxel-weights. The colours represent the rAUC (ratio between AUC- and AUC +) for each selected ROI in the BA atlas. For clarity, rAUC was normalized independently for each modality so that cool colours (from purple to light blue) always represent rAUC \< 1 (i.e., regions with predominantly positive voxel-weights). In the same way, warm colours (from yellow to red) represent rAUC \> 1 (regions with predominantly negative voxel-weights) and greenish colours represent regions with rAUC close to 1 (no clear predominance of signal).Fig. 7

4. Discussion {#s0090}
=============

To the best of our knowledge, the present study is the first to compare the diagnostic performance of two different SVM approaches (MKL-ROI-based and whole-brain-based) to discriminate patients with mild AD from age- and gender-matched healthy controls using multimodal neuroimaging data acquired in exactly the same subjects with short inter-scanning intervals. The use of the MKL-ROI approach to rank brain regions allowed us to highlight the foci with greatest discriminating ROI-weight to distinguish AD patients from healthy controls across the three imaging modalities employed (T1-MRI, ^18^F-FDG-PET and rCBF SPECT), with analyses repeated using two different brain atlases.

Regardless of the atlas employed, the MKL-ROI analysis of PET data indicated highest discriminating ROI-weight afforded by medially located posterior cortical regions (medial parietal cortex encompassing the precuneus and posterior cingulate gyrus). This pattern of results is highly consistent with the findings of previous functional imaging studies that conducted statistical group comparisons or visual inspection of individual PET data from patients suffering from AD or amnestic mild cognitive impairment (MCI) compared to elderly controls; these investigations have highlighted the relevance of metabolic hypoactivity in the posterior cingulate gyrus (BA 23) and medial parietal cortex (BA 7) among the most characteristic features of the prodromal phase of AD and early stages of dementia ([@bb0125], [@bb0210], [@bb0230], [@bb0325]). It is relevant to note that these brain regions alone were responsible for approximately 25% and 40% (using the AAL and BA atlases, respectively) of the ROI-weight of discrimination between AD patients and controls in our MKL-ROI analysis of PET data. Our results indicate that such localized foci of brain hypoactivity have very strong voxel-weight in the discrimination between patients with early AD and elderly controls when SVM-based methods are applied to PET data. It is widely known that local molecular and neuropathological changes and disconnection patterns that characterize AD may begin several years before any cognitive deficits emerge ([@bb0075], [@bb0220]), slowly progressing in a spreading fashion across cortical and subcortical brain regions ([@bb0030], [@bb0075]). Our PET findings reinforce the view that the macroscopic brain metabolic patterns that most critically typify the probable diagnosis of AD on an individual basis remain relatively localized even when clear symptoms of dementia are already present. By highlighting the same brain regions emphasized in previous studies investigating the clinical utility of ^18^F-FDG-PET data to allow diagnostic predictions in individual elderly subjects ([@bb0125]), our findings strengthen the potential usefulness of ML-based approaches in clinical practice.

When comparing the MKL-ROI-based findings obtained with SPECT with the results of the same analysis using PET data, we found a considerable degree of coincidence in regard to the brain regions that had the largest ROI-weight of discrimination between AD patients and healthy controls between the two functional imaging modalities, particularly in regard to medially located posterior cortical regions (medial parietal cortex encompassing the precuneus and posterior cingulate gyrus). Taking into account the results based on the BA atlas, there was also concordance in the MKL-ROI-based analysis of PET and SPECT data in regard to the considerable ROI-weight attributed to the medial temporal region, despite some differences in the exact location of the temporolimbic findings between the SPECT (parahippocampal gyrus and perirhinal cortex -- BA 36 and BA 27) and PET (perirhinal cortex only -- BA 36) analyses. The coincidence between MKL-ROI-based ranking profiles obtained with PET and SPECT data reinforces the validity of the spatial pattern of rCBF deficits mapped by SPECT when compared to the location of the brain metabolic abnormalities typically delineated with FDG-PET in AD patients when compared to elderly controls ([@bb0175]).

Since we corrected both PET and SPECT data for PVE, it is unlikely that the large ROI-weight attributed to functional abnormalities in postero-medial cortical regions and temporo-limbic structures in our study was due to PVE introduced by brain atrophy in those regions. This strengthens the view that functional neuroimaging methods applied to the diagnosis of AD provide high sensitivity to uncover localized patterns of functional hypoactivity in regions critical to the pathophysiology of AD regardless of the presence of brain atrophy in the same locations ([@bb0205]).

There were important differences in regard to the labeling and ranking of brain regions between the analyses carried out with the two atlases for PET and SPECT data. For instance, in regard to the ROI-weights attributed to medially located posterior cortical regions (precuneus and posterior cingulate gyrus), the BA atlas produced larger values for both PET and SPECT data (above 40%) compared to the AAL atlas (around 25% for PET and 29% for SPECT, respectively). Also, much larger ROI-weights were attributed to functional patterns in medial temporal cortical regions (mainly perirhinal cortex for PET, and parahippocampal plus perirhinal cortices for SPECT) when the BA atlas was used as compared to the AAL atlas (which attributed only small ROI-weights to the parahippocampal gyrus and hippocampus). In both AD and MCI, different results depending on the atlas employed have been repeatedly reported in previous ML-based studies based on the use of ROIs ([@bb0265], [@bb0260], [@bb0375]). This is to be expected, given their considerable differences in regard to the size and boundaries of the ROIs employed between the AAL and BA templates ([@bb0260]).

Despite some differences between atlases, the discrimination between AD patients and controls using the T1-MRI GM data in our study also highlighted medially located posterior cortical regions (particularly the posterior cingulate gyrus) and temporolimbic structures (mainly entorhinal cortex and inferior temporal region for the Brodmann-based analysis and the amygdala and the inferior and superior temporal gyri for the AAL-based analysis). One notable finding regarding the T1-MRI analysis regarded the greatest emphasis given to atrophy located in the lateral temporal neocortex (whichever the atlas employed), which was not highlighted in the ranking analyses for PET or SPECT data. Such T1-MRI findings are consistent with the results of previous mean group comparisons of patients with mild AD and elderly controls using voxel-based morphometry methods, which have reported prominent findings of reduced GM volume of the lateral temporal neocortex in AD ([@bb0045], [@bb0080]). A high discrimination ROI-weight for lateral temporal atrophy (based on T1-MRI) not accompanied by discriminative hypoactivity in the same regions (based on PET or SPECT imaging) is an intriguing pattern that awaits replication in future investigations with larger samples.

It is important to emphasize, however, that there is a mismatch of brain structures included in each ROI across the atlases. For example, the dorsal entorhinal cortex (Brodmann area 34) received the highest weight when classifying T1 images using the Brodmann atlas ([Table 4](#t0020){ref-type="table"}). However, there is no specific ROI delimitating the entorhinal region in the AAL atlas. The dorsal entorhinal ROI of the Brodmann atlas has a high degree of overlap with the amygdala ROI from the AAL atlas. Not surprisingly, the amygdala ROI received a high weight when classifying T1 images using the AAL atlas ([Table 3](#t0015){ref-type="table"}). Therefore, it is possible that 1) atrophic changes in the entorhinal cortex were more precisely labelled when using the Brodmann atlas, and that 2) these changes reflected in a high weight to the amygdala ROI when using the AAL atlas. We illustrate the overlap across the atlases in these areas in [Fig. S1](#f0040){ref-type="graphic"} (supplementary material).

One novel aspect of our investigation consisted in the calculation of the rAUC, the ratio between the positive and negative voxel-weights in each selected ROI. This strategy allowed us to identify a few ROIs in which the ROI-weight of discrimination was due to a pattern of increased voxel-weight values in AD individuals present in all modalities. Surprisingly, the ROI-weights attributed to such regions were far from negligible, ranging from approximately 20% to 40% of the discrimination between AD patients and controls depending on the imaging modality. The main brain regions in which such pattern of increased voxel values in AD patients relative to controls was apparent are known to be spared by neurodegenerative AD-related processes until late stages of dementia ([@bb0045], [@bb0330], [@bb0355]), including the somatosensory cortex (BA 3, BA 43), primary motor cortex (BA 4), basal ganglia, thalamus and visual cortex (BA17 and BA18). Other recent SVM investigations of FDG-PET data have reported similar findings, with the somatosensory cortex among the brain regions showing highest discrimination between MCI patients converting to AD and healthy controls ([@bb0270]). Apparent functional hyperactivity in brain regions known to be spared until late stages of AD has been reported in previous PET and SPECT studies that performed mean group comparisons against elderly controls ([@bb0090], [@bb0270], [@bb0345]); since the metabolic activity and cerebral blood flow in AD individuals is decreased in many GM areas, data normalization of count values in each ROI to the global tracer uptake in the brain leads to an overestimation of the relative activity measures in AD subjects in the selected brain regions that are most notably spared by the neurodegenerative AD process ([@bb0090]). The findings reported herein demonstrate that the classification of voxels with increased values in AD patients relative to healthy controls make an important contribution to their diagnostic discrimination when SVM-based methods are applied to PET, SPECT or T1-MRI data.

The present investigation also aimed to compare diagnostic accuracy indices obtained with the MKL-ROI approach to the indices obtained with SVM based on the whole-brain. There has been some degree of controversy in previous ML-based neuroimaging studies of AD in regard to whether greater diagnostic accuracy for the diagnosis of AD is afforded when analyses are based on whole-brain data or, instead, selected brain regions thought to be critical to the pathophysiology of AD ([@bb0060], [@bb0165], [@bb0270]). We found some support to the latter prediction, since there was a clear increment in accuracy for PET data when applying the MKL-ROI-based method (with both the AAL and BA atlases) as compared to whole-brain findings, due to an increased ability to avoid false positives. This is a potentially relevant finding, and we argue that such accuracy increment may be explained by the large ROI-weights attributed specifically to postero-medial cortical regions in the MKL-ROI-based analyses, including the posterior cingulate gyrus (in the Brodmann-based analysis) and the precuneus (in the AAL-based analyses). It is interesting to note that such increment in diagnostic accuracy seen for ^18^F-FDG-PET data was not obtained for rCBF SPECT data; this is consistent with the findings of recent direct comparisons that favour the use of ^18^F-FDG-PET rather than rCBF-SPECT for the diagnosis of AD when accuracy is measured with basis on visual inspection of key brain regions by experts ([@bb0250]). When we compared the accuracy indices afforded by the two SVM methods specifically for the T1-MRI data, results were less conclusive than those for ^18^F-FDG-PET. With MKL-ROI using the AAL atlas, the number of AD patients correctly classified did increase slightly for T1-MRI data; however, we actually found some degree of decrement in accuracy for T1-MRI data when the MKL-ROI-based method with the BA atlas was used in comparison to the whole-brain analysis, driven by a slightly lesser ability to correctly classify healthy controls as true negatives.

Limitations of the present investigation must be acknowledged, such as the modest size of the samples recruited. It is plausible to predict that greater power afforded by the use of samples of larger size would produce larger diagnostic accuracy indices than those reported herein ([@bb0105]). On the other hand, even if modest in size, our sample was sufficient to allow a ranking profile of brain regions that is highly consistent with previous neuroimaging findings and pathophysiological models of AD. Moreover, the MKL-ROI analysis of PET data (using either of the two atlases) produced a balanced accuracy above 90%, a measure that is highly similar to accuracy indices reported in previous studies carried out with larger samples ([@bb0380]). We should also acknowledge that although we employed state-of-the-art methods to correct functional neuroimaging data for PVE, such PVE correction methodology has been validated for ^18^F-FDG-PET rather than SPECT rCBF data.

In conclusion, the MKL-ROI approach used in the present SVM-based multimodal neuroimaging investigation highlighted brain areas of known relevance to the pathophysiology of AD (namely the posterior cingulate gyrus, precuneus and temporo-limbic cortical regions) as highly discriminative in the comparison of patients with mild AD patients versus age- and gender-matched healthy controls, particularly in the analyses carried out using functional imaging data (^18^F--FDG-PET or rCBF SPECT). Moreover, the MKL-ROI strategy allowed us to demonstrate that voxels located in other brain regions known to be spared by AD-related neurodegenerative changes also provide substantial contribution to the SVM-based discrimination between AD and elderly control individuals, consistently across structural and functional neuroimaging modalities. Finally, while similar diagnostic accuracy indices were obtained with the MKL-ROI and whole-brain methods for T1-MRI and rCBF SPECT data, there was an increment in accuracy for the PET data when applying the MKL-ROI-based method (with both atlases), again underscoring the relevance of functional activity decrements in circumscribed posterior cortical regions as a critical imaging feature for the early diagnosis of AD.

The following is the supplementary data related to this article.Fig. S1Overlap between the ROI corresponding to the amygdalae of the AAL atlas (red) and the dorsal entorhinal cortex of the Brodmann atlas (blue). The ROIs were superimposed on an anatomical brain template. The figure shows that there is a high degree of overlap between the ROIs across the atlases.Fig. S1
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[^1]: AD -- Alzheimer\'s disease; SD -- standard deviation. The *p*-value was obtained using chi-square (for gender) and Mann-Whitney tests (for the continuous variables).

[^2]: T1-MRI: T1-weighted magnetic resonance imaging; ^18^F-FDG-PET: ^18^F-fluorodeoxyglucose-positron emission tomography; rCBF-SPECT: regional cerebral blood flow single photon emission computed tomography; NSR: Number of selected ROIs (assigned non-zero ROI-weight); NF: number of features (voxels) in the set of selected ROIs; TP: true positive (percentage of patients correctly classified); TN: true negative (percentage of healthy controls correctly classified); BA: balanced accuracy; *p*: statistical significance given by permutation.

[^3]: T1-MRI: T1-weighted magnetic resonance imaging; ^18^F-FDG-PET: ^18^F-fluorodeoxyglucose-positron emission tomography; rCBF SPECT: regional cerebral blood flow single photon emission computed tomography; ROI: region of interest obtained from AAL atlas. rAUC: ratio between areas under curve corresponding to negative and positive voxel-weights (values close to zero reflect a predominance of positive values whereas values above 1 are found in regions with predominant negative values). The words *orbitalis* and *triangularis.* were abbreviated as orb. and tri., respectively, and the words sup*erior* and inf*erior* were abbreviated as sup. and inf., respectively. The brain regions that were selected in all three modalities were highlighted in dark blue. Regions that were selected in both functional modalities (^18^F-FDG-PET and rCBF-SPECT) were highlighted in medium blue. Regions that were selected in both T1-MRI and one of the functional modalities (either ^18^F-FDG-PET or CBF-SPECT) were highlighted in light blue. For each modality (T1-MRI, ^18^F-FDG-PET and CBF-SPECT), the selected ROIs were sorted in descending order of ROI-weight.

[^4]: T1-MRI: T1-weighted magnetic resonance imaging; ^18^F-FDG-PET: ^18^F-fluorodeoxyglucose-positron emission tomography; rCBF SPECT: regional cerebral blood flow single photon emission computed tomography; BA: Brodmann\'s area; ROI: region of interest obtained from BA atlas;. rAUC: ratio between the areas under curve corresponding to negative and positive voxel-weights (values close to zero reflect a predominance of positive values whereas values above 1 are found in regions with predominant negative values). The words *orbitalis* and *triangularis.* were abbreviated as orb. and tri., respectively, and the words *cortex* and *gyrus* were abbreviated as ctx. and gr., respectively. The brain regions that were selected in all three modalities were highlighted in dark blue. Regions that were selected in both functional modalities (^18^F-FDG-PET and rCBF-SPECT) were highlighted in medium blue. Regions that were selected in both T1-MRI and one of the functional modalities (either ^18^F-FDG-PET or rCBF-SPECT) were highlighted in light blue. For each modality (T1-MRI, ^18^F-FDG-PET and rCBF-SPECT), the selected ROIs were sorted in descending order of ROI-weight.
